InsiderCluster

INM

NasdaqCM

InMed Pharmaceuticals Inc.

$1.51
▼ -0.07 (-4.43%)

Price

-1.63% over 1D

Key statistics

Previous close$1.58
Day range1.50 – 1.56
52-week range0.58 – 5.50
Volume39.07K
CurrencyUSD
ExchangeNasdaqCM
Crowd sentiment
92Bullish

Insider activity

SEC EDGAR ↗
Open-mkt buys
21
$1,113,102.40
Open-mkt sells
0
$0.00
Net flow
+1.11M
21 open-market trades

Showing 29 recent filings. 8 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.

InsiderTypeSharesPriceValueDate
Vivo Opportunity, LLC
10% Owner
Buy (open market)51.06K$1.56$79,647.362026-05-20
Vivo Opportunity, LLC
10% Owner
Buy (open market)5.15K$1.56$8,040.242026-05-20
Vivo Opportunity, LLC
10% Owner
Buy (open market)30.88K$1.69$52,190.582026-05-21
Vivo Opportunity, LLC
10% Owner
Buy (open market)3.12K$1.69$5,269.422026-05-21
Vivo Opportunity, LLC
10% Owner
Buy (open market)16.16K$1.57$25,377.482026-05-29
Vivo Opportunity, LLC
10% Owner
Buy (open market)1.63K$1.57$2,562.242026-05-29
Vivo Opportunity, LLC
10% Owner
Buy (open market)14.84K$1.55$22,998.902026-06-01
Vivo Opportunity, LLC
10% Owner
Buy (open market)1.5K$1.55$2,321.902026-06-01
Vivo Opportunity, LLC
10% Owner
Buy (open market)20.75K$1.52$31,544.562026-06-02
Vivo Opportunity, LLC
10% Owner
Buy (open market)2.1K$1.52$3,184.402026-06-02
Vivo Opportunity, LLC
10% Owner
Buy (open market)7.07K$1.55$10,956.952026-06-03
Vivo Opportunity, LLC
10% Owner
Buy (open market)714$1.55$1,106.702026-06-03
Vivo Opportunity, LLC
10% Owner
Buy (open market)6.13K$1.57$9,616.252026-06-04
Vivo Opportunity, LLC
10% Owner
Buy (open market)618$1.57$970.262026-06-04
Vivo Opportunity, LLC
10% Owner
Buy (open market)49.97K$1.57$78,446.622026-06-05
Vivo Opportunity, LLC
10% Owner
Buy (open market)5.05K$1.57$7,920.652026-06-05
Vivo Opportunity, LLC
10% Owner
Buy (open market)29.52K$1.52$44,867.362026-06-08
Vivo Opportunity, LLC
10% Owner
Buy (open market)2.98K$1.52$4,532.642026-06-08
ADAR1 Capital Management, LLC
10% Owner
Buy (open market)68.55K$1.60$109,667.892026-05-19
ADAR1 Capital Management, LLC
10% Owner
Buy (open market)200K$1.56$312,080.002026-05-19
ADAR1 Capital Management, LLC
10% Owner
Buy (open market)200K$1.50$299,800.002026-05-19
Johnson Shane Aaron
Sr VP & General Manager
Grant / award8.5K$0.00—2025-12-19
Lemerond Nicole
Director
Grant / award1.75K$0.00—2025-12-19
Klompas Neil A
Director
Grant / award1.75K$0.00—2025-12-19
Jagpal Netta
Chief Financial Officer
Grant / award18K$0.00—2025-12-19
WOUDENBERG MICHAEL
Chief Operating Officer
Grant / award18K$0.00—2025-12-19
Bathery John Steven
Director
Grant / award1.75K$0.00—2025-12-19
HSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
Grant / award13K$0.00—2025-12-19
ADAMS ERIC A
Director, President & CEO
Grant / award35K$0.00—2025-12-19

Source: SEC EDGAR Forms 4/4A (CIK 1728328). Click an insider to open the original filing.

Social sentiment

92
Bullish

Volume-weighted across live social sources

StockTwitsLIVE
12 bull921 bear
Recent posts
@AlertsAndNews· StockTwits4d ago

$INM 10%er buy here Vivo Opportunity Cayman Fund, L.P. (10%+) purchased 249,227 shares at an average price of $1.57 (Form 4).

@newsfile_corp· StockTwitsJun 4

https://nfne.ws/300271 $INM @inmedpharma #inm #inmed #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

@jerchess· StockTwitsJun 1

$INM cheers !!!https://www.youtube.com/live/QowyPM6Zt4g?si=amMmpIkCX0gvgZ4m

@SuperGreenToday· StockTwitsMay 28

$INM

@Waytobe360· StockTwitsMay 22

$INM sold out at 1.9, not much steam

@Gelato1017· StockTwitsMay 22

$INM only going up

@nonoaaaaa· StockTwitsMay 22

$EZRA $GOVX $INM $NXL $OFAL

@JLCw· StockTwitsMay 22

Final Watchlist Friday 05/22 $GOVX $INM $OFAL $NXL $EZRA More speculative continuationplays but still seeing decent volume/catalyst interest. Watching for PM volume and breakout reclaims tomorrow JL

@sam6666· StockTwitsMay 22

$INM is dead...read the news

@BobJobb· StockTwitsMay 21

$INM

@BillionaireMotion· StockTwitsMay 21

You miss all the insane 400%+ squeezers ??! Make sure to keep ticker EZRA on watch ! Starting to make a move now.. I really hope the shorts get squeezed out hard. EZRA barely has 550k shares remaining to the public . We saw a mini spike earlier.. Would not be shocked at all if it runs soon. Always try to buy early before the crowd does 🚀 News on $HCWB $PIII $INM $AMST too

@FilingTracker· StockTwitsMay 21

$INM Insider purchase by 10% owner at $1.54/share: https://www.sec.gov/Archives/edgar/data/1728328/000194027226000008/0001940272-26-000008-index.htm

Latest news

InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements

TMX Newsfile·Jun 4Neutral

/C O R R E C T I O N -- InMed Pharmaceuticals/

PR Newswire·May 20Neutral

InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM)

InvestorsHub·May 19Neutral

BC-Most Active Stocks

Associated Press·May 19Neutral

A migraine drugmaker heads to the public markets through reverse merger

BioPharma Dive·May 19Neutral

InMed Pharmaceuticals Amends Preferred Investment Options

TMX Newsfile·May 19Neutral

InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

TMX Newsfile·May 6Neutral

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

TMX Newsfile·Mar 27Neutral

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

TMX Newsfile·Mar 23Neutral

Sidoti Events, LLC's March Small-Cap Virtual Conference

ACCESS Newswire·Mar 18Neutral

Get insider-buy alerts

Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.